InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the full record of transactions filed by Nicholson Garry A, 董事. Director active across 1 company, notably G1 Therapeutics, Inc.. Aggregated, 5 reports have been recorded. Activity tracked since 17 June 2021. The latest transaction was filed on 13 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Nicholson Garry A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
20,000 股Common StockSEC:0000950170-24-107797:0
10,000 股0Common StockSEC:0001562180-24-005078:0
10,000 股0Common StockSEC:0001562180-23-005264:0
10,000 股0Common StockSEC:0001562180-22-005353:0
4,389 股0Common StockSEC:0001562180-21-004393:0
5 条申报中的 5 条
About Nicholson Garry A
Garry A. Nicholson is a Board Member at G1 Therapeutics, Inc. He contributes to the strategic direction of the company, participating in key decisions that influence its development. His expertise in the biopharmaceutical sector is valuable to the board, enabling G1 Therapeutics to navigate effectively in a competitive environment.
